Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva's $40.5 billion generics deal with Allergan hits FTC snag
Teva's $40.5 billion generics deal with Allergan hits FTC snag
Teva's $40.5 billion generics deal with Allergan hits FTC snag
Submitted by
admin
on March 15, 2016 - 10:16pm
Source:
BioPharma Dive
News Tags:
Teva Pharmaceutical
Allergan
generics
FTC
M&A
Headline:
Teva's $40.5 billion generics deal with Allergan hits FTC snag
Do Not Allow Advertisers to Use My Personal information
